SunCoke Energy, Inc. (SXC)
NYSEMaterialsSteelSnapshot 2026-10-29
NYSEMaterialsSteelSnapshot 2026-10-29
Research Workspace
Put SXC beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Materials: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Management is running behind on a stated commitment.
View ThesisRevenue is growing steadily — about 3% over the past year.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look high — what the market is pricing in runs ahead of what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 32% in its worst 12-month stretch.
View RiskSXC’s earnings recovery and raised 2026 EBITDA outlook support the case for improving performance. Revenue grew 9.5% year over year in Q2 FY2026, and third-quarter GAAP earnings beat consensus. SXC trades at 44× P/E versus the 17× peer median. The market is pricing in more growth than our forecast, leaving expectations full. The 28% next-quarter miss probability and management’s missed commitment threaten confidence. The 44× multiple must be earned despite the peer gap. Peer multiples imply a price about 16% below where it trades; the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. SXC is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 2 analysts currently covering SXC (as of Oct 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare SXC with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| SXC Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Coal & Consumable Fuels — fair value, gap to price, and forward P/E.
Compare the value case
Put SXC next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Increase full-year 2026 Consolidated Adjusted EBITDA to $250M-$265M
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
EBITDA outlook exceeds the top of guidance and higher free cash flow materially strengthens the outlook.

Advances: Increase full-year 2026 Consolidated Adjusted EBITDA to $250M-$265M
Reported earnings beat and raised guidance support the 2026 EBITDA objective, pending details.

Advances: Increase full-year 2026 Consolidated Adjusted EBITDA to $250M-$265M
Reported earnings and revenue beats support operating performance, though no objective-level details are given.

Advances: Deliver 3.4 million tons of domestic coke sales in 2026
Operational improvements support domestic coke sales target.